Overview : Aenco is a "one-stop shop" platform with the objective to deliver cutting-edge institutional financing, prime brokerage, and smart capital solutions for the HealthTech industry, as well as a research and collaboration hub for healthcare companies and projects involved in the field of blockchain development. Aenco consists of a team with years of experience from global investment banks and financial institutions, as well as blockchain technologists and enthusiasts.
Aenco (AEN) ICO Review, Ratings, Token Price
| Name | Aenco : Blockchain-Based Healthcare Financial Solutions Platform |
| Ticker | AEN |
| Token Type | ERC223 |
| Token Price | 1 AEN = 0.1 USD |
| Available for Token Sale | 600,000,000 AEN (15%) |
| Pre-Sale Date | 07/27/2018 – 08/31/2018 |
| Main Sale Date | 09/01/2018 – 09/30/2018 |
| Review | - |
Aenco is a blockchain based global financial solutions platform, combining decades of experience in traditional financial services and prime brokerage, with network of Healthcare technology (“HealthTech”) innovation partners and new-age applications, collectively developed under the umbrella “Aenco Global HealthTech Financial Solutions platform”.
What is special about Aenco?
Aenco is the world’s FIRST Blockchain based Healthcare Technology Financial Solutions Platform that leverages healthcare technologies with institutional financing, prime brokerage and smart capital solutions under one umbrella.
Aenco is a “one stop shop” for the delivery of cutting edge institutional financing, prime brokerage and core smart capital solutions for the HealthTech industry, as well as a research and collaboration hub for healthcare companies and projects involved in the field of blockchain development.
Aenco will be combining its solutions platform and core financial ecosystem with the wider healthcare technology community, through the AEN token, as the key ecosystem building block and extensions across ALL its service and community deliveries.
The Aenco platform empowers emerging and innovative healthcare companies with digital financing capabilities, so that they can focus on generating high potential and impactful technologies that can transform our world and day to day lives.
Aenco is supported by the group’s planned regulated infrastructure (including the establishment of a commercial bank within the group) and presence in major jurisdictions including Europe, Hong Kong, and the United States, through which Aenco will effectively deliver its solutions, generating an increasing and rapidly evolving ecosystem.
Token Info |
|---|
| Token | AEN |
| Platform | Ethereum |
| Type | ERC223 |
| Token price | 1 AEN = 0.1 USD |
| Tokens for sale | 600,000,000 AEN |
| Tokens supply | 4,000,000,000 AEN |
| Token Distribution | Mining Rewards = 49.85% Company and Team = 21.00% Token for Sale = 15.00% Bonus = 14.15% |
| Token Allocation | Sponsorship and Financial Solutions Platform for HealthTech Partners = 40.00% Research, Techonology Development and Roll Out and Collaboration Research = 30% General Working Capital and Infrastructure Setup Capital Requirement = 24% Marketing and Distribution = 3.00% Legal and Compliance = 3.00% |
Investment Info |
|---|
| Soft cap | 15,000,000 USD |
| Hard cap | 60,000,000 USD |
| Restricted countries | China, United States of America, Samoa, Sanctioned Countries |
| Whitelist / KYC | Yes / Yes |
| Accepting | ETH, BTC |
| Pre-sale Date | 07/27/2018 – 08/31/2018 |
| Main Sale Date | 09/01/2018 – 09/30/2018 |
| Bonus | Pre-Sale › 15 ETH = 50% › 5 ETH and ≤ 15 ETH = 40% ≥ 1 ETH and ≤ 5 ETH = 30% *First 24 Hours of Pre-Sale = +5% additional Main Sale Week 1 = 15% Week 2 = 10% Week 3 = 5% Week 4 = 0% |
| 2005 | Aeneas Capital grante Asset Management license by SFC (Hong Kong) |
| 2008-2009 | Fund products generate positive returns throughout subprime crisis |
| Q4 2010 | Assets managed by Aeneas deployed into health care private equity and direct investments |
| Q2 2016 | Aeneas Group builds healthtech partnership with Aptorum Group, a multi-disciplinary medical innovations platform based in HK |
| Q3 2017 | Aeneas Capital initiates to expand its licenses with the SFC in HK to include dealing and advising in securities; Aeneas expands partnerships with healthtech companies specializing in neuro, infectious diseases, and robotic surgery devices. |
| Q1 2018 | Aeneas Capital, LLC. established in New Jersey, U.S.A. to set up a FINRA regulated broker dealer (in progress); Aeneas Group establishing a full-service banking license in Europe (in progress). |
| Q2 2018 | June Initiate Private Sale; Aeneas Capital granted expanded licenses by the SFC in HK to deal and advise in securities; Community investors outreach. |
| Q4 2018 | Expand team: Developers; 1st pipeline healthtech; ICO launch; Launch first generation smart wallet & infrastucture (AEN Connect) |
| Q4 2019 | Second generation: AENX trading exchange |
| Q2 2020 | Third generation: AENCO prime brokerage platform; Ongoing service & expansion of pipeline HealthTech partners. |
 | 8.5 / 10.0 |
 | 4.5 / 5.0 |
 | 5.0 / 5.0 |
 | 82 / 100 |
 | 4.4 / 5.0 |
Bitcointalk Profile Link: https://bitcointalk.org/index.php?action=profile;u=1114528
Donation:
ETH (ERC-20) Address: 0x86Ad36da59310683CfE8C2c66e798D2e636413fF
Bitcoin Address: 16DcB1iCq9rQ4PKQZUU8XhNcQ5qRCPmGsZ
Posting Komentar